Laennek

Laennek is a hepatoprotective and immunomodulating drug containing human placenta hydrolysate. It is used as part of combination therapy for various conditions, including chronic recurrent herpes and atopic dermatitis.

Indications for Use:

1. Chronic recurrent herpes (as part of combination therapy).
2. Atopic dermatitis of moderate to severe forms, including complicated cases (as part of combination therapy).
3. Chronic liver diseases, such as steatohepatitis of alcoholic, metabolic, or mixed origin (as monotherapy).

Contraindications:

• Known hypersensitivity to any components of the drug.
• Pediatric use (not recommended in children).
• Pregnancy and breastfeeding.

Side Effects:

1. Local Reactions: Pain, redness, itching, or numbness at the injection site.
2. Allergic Reactions: Rare but potentially serious allergic responses, including anaphylactic shock.
3. Other: Reports of gynecomastia (causal relationship with the drug has not been confirmed).

Special Instructions:

• Use with caution in patients with a history of polyvalent drug allergies and in elderly individuals.
• The drug's effect on the ability to drive vehicles or operate machinery has not been established.
• Consultation with a healthcare professional is strongly recommended before starting treatment with Laennek to develop an optimal treatment plan and minimize risks. Self-medication is not advised and may lead to adverse effects.

• Injection solution: transparent liquid from light yellow to brown with a characteristic odor.
• Packaged in 2 ml dark glass ampoules.